HRP20110184T1 - Postupak priprave 5-(haloacetil)-8-(supstituirani oksi)-(1h)-kinolin-2-ona - Google Patents

Postupak priprave 5-(haloacetil)-8-(supstituirani oksi)-(1h)-kinolin-2-ona Download PDF

Info

Publication number
HRP20110184T1
HRP20110184T1 HR20110184T HRP20110184T HRP20110184T1 HR P20110184 T1 HRP20110184 T1 HR P20110184T1 HR 20110184 T HR20110184 T HR 20110184T HR P20110184 T HRP20110184 T HR P20110184T HR P20110184 T1 HRP20110184 T1 HR P20110184T1
Authority
HR
Croatia
Prior art keywords
quinolin
hydroxy
acetyl
substituted oxy
solvent
Prior art date
Application number
HR20110184T
Other languages
English (en)
Croatian (hr)
Inventor
Lohse Olivier
Penn Gerhard
Schilling Hanspeter
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=33131902&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HRP20110184(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of HRP20110184T1 publication Critical patent/HRP20110184T1/hr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20Oxygen atoms
    • C07D215/24Oxygen atoms attached in position 8
    • C07D215/26Alcohols; Ethers thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J31/00Catalysts comprising hydrides, coordination complexes or organic compounds
    • B01J31/02Catalysts comprising hydrides, coordination complexes or organic compounds containing organic compounds or metal hydrides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13Crystalline forms, e.g. polymorphs
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pulmonology (AREA)
  • Materials Engineering (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Quinoline Compounds (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
HR20110184T 2003-04-02 2004-04-01 Postupak priprave 5-(haloacetil)-8-(supstituirani oksi)-(1h)-kinolin-2-ona HRP20110184T1 (hr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US45972403P 2003-04-02 2003-04-02
PCT/EP2004/003479 WO2004087668A1 (en) 2003-04-02 2004-04-01 A process for the preparation of 5-(haloacetyl)-8-(substituted oxy)-(1h)-quinolin-2-ones

Publications (1)

Publication Number Publication Date
HRP20110184T1 true HRP20110184T1 (hr) 2011-04-30

Family

ID=33131902

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20110184T HRP20110184T1 (hr) 2003-04-02 2004-04-01 Postupak priprave 5-(haloacetil)-8-(supstituirani oksi)-(1h)-kinolin-2-ona

Country Status (34)

Country Link
US (1) US7605267B2 (enExample)
EP (1) EP1613599B8 (enExample)
JP (1) JP4726778B2 (enExample)
KR (1) KR101073740B1 (enExample)
CN (1) CN1774423A (enExample)
AR (2) AR043825A1 (enExample)
AT (1) ATE491690T1 (enExample)
AU (1) AU2004226212B2 (enExample)
BR (1) BRPI0409154B1 (enExample)
CA (1) CA2520990C (enExample)
CL (1) CL2004000706A1 (enExample)
CO (1) CO5700779A2 (enExample)
CY (1) CY1111515T1 (enExample)
DE (1) DE602004030553D1 (enExample)
DK (1) DK1613599T3 (enExample)
EC (1) ECSP056059A (enExample)
ES (1) ES2358193T3 (enExample)
HR (1) HRP20110184T1 (enExample)
IL (1) IL171053A (enExample)
IS (1) IS2800B (enExample)
MA (1) MA27761A1 (enExample)
MX (1) MXPA05010616A (enExample)
MY (1) MY141871A (enExample)
NO (1) NO331980B1 (enExample)
NZ (1) NZ542623A (enExample)
PE (2) PE20050211A1 (enExample)
PL (1) PL1613599T3 (enExample)
PT (1) PT1613599E (enExample)
RU (1) RU2339621C2 (enExample)
SI (1) SI1613599T1 (enExample)
TN (1) TNSN05245A1 (enExample)
TW (1) TWI324151B (enExample)
WO (1) WO2004087668A1 (enExample)
ZA (1) ZA200507603B (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0411056D0 (en) 2004-05-18 2004-06-23 Novartis Ag Organic compounds
GB0413960D0 (en) * 2004-06-22 2004-07-28 Novartis Ag Organic compounds
DK2044025T3 (da) 2006-06-30 2013-01-14 Novartis Ag Quinolinonderivater samt farmaceutiske sammensætninger deraf
WO2013132514A2 (en) * 2012-03-09 2013-09-12 Rao Davuluri Ramamohan A novel process for the preparation of (r)-5-[2-[(5, 6-diethyl-2, 3-dihydro-1h-inden-2-yl) amino]-1-hydroxyethyl]-8-hydroxy quinolin-2(1h)-one
CN102633717B (zh) * 2012-03-30 2013-11-20 西南大学 N-乙酰-喹啉-2(1h)酮类化合物及其制备方法和应用
CN104379566B (zh) * 2012-07-11 2016-08-24 上海威智医药科技有限公司 茚达特罗中间体及茚达特罗的合成方法
CZ306252B6 (cs) 2013-03-15 2016-10-26 Zentiva, K.S. Způsob přípravy 5-[(R)-2-(5,6-diethylindan-2-ylamino)-1-hydroxyethyl]-8-hydroxy-(1H)-chinolin-2-onu (indacaterolu)
PT3092217T (pt) 2014-01-09 2020-09-04 Ramamohan Rao Davuluri Processo inovador para preparação de indacaterol ou dos seus sais farmaceuticamente aceitáveis
CN105693603B (zh) * 2014-11-24 2019-11-29 上海医药工业研究院 改良的马来酸茚达特罗制备工艺
CN107531636B (zh) * 2015-04-09 2022-11-25 正大天晴药业集团股份有限公司 茚达特罗或其盐的制备方法
CN107868045A (zh) * 2016-09-28 2018-04-03 四川海思科制药有限公司 一种茚达特罗中间体的制备方法
CN108264483A (zh) * 2016-12-31 2018-07-10 天津金耀集团有限公司 一种马来酸茚达特罗的制备方法
CN109721534B (zh) * 2018-09-25 2022-05-20 四川海思科制药有限公司 一种马来酸茚达特罗中间体及其制备方法和用途
CN114751857A (zh) * 2022-04-29 2022-07-15 梯尔希(南京)药物研发有限公司 一种茚达特罗杂质的制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS539228B2 (enExample) * 1974-01-31 1978-04-04
CA1164459A (en) * 1980-11-11 1984-03-27 Yung-Hsiung Yang Process for preparing (imidazo¬1,2-a|pyridine- 2-yl)-carbostyril or -3,4-dihydrocarbostyryl derivatives
JPS5896022A (ja) * 1981-11-30 1983-06-07 Otsuka Pharmaceut Co Ltd 強心剤
ES519384A0 (es) * 1983-01-28 1984-03-16 Espanola Farma Therapeut Procedimiento para la obtencion de un compuesto derivado de la 2-quinolinona.
ES8605239A1 (es) * 1985-12-04 1986-03-16 Astur Pharma Un procedimiento para la preparacion de quinolonas sustitui-das
US4894219A (en) * 1988-03-29 1990-01-16 University Of Florida Beta-agonist carbostyril derivatives, assay method and pharmacological composition
GB9405019D0 (en) * 1994-03-15 1994-04-27 Smithkline Beecham Plc Novel compounds
JP2000510865A (ja) * 1996-05-20 2000-08-22 ダーウィン・ディスカバリー・リミテッド Tnfとpde―ivのインヒビターとしてのキノリンカルボキサミド
GB9913083D0 (en) 1999-06-04 1999-08-04 Novartis Ag Organic compounds
GB0029562D0 (en) * 2000-12-04 2001-01-17 Novartis Ag Organic compounds
US6653323B2 (en) * 2001-11-13 2003-11-25 Theravance, Inc. Aryl aniline β2 adrenergic receptor agonists
TWI324150B (en) * 2003-02-28 2010-05-01 Novartis Ag Process for preparing 5-[(r)-2-(5,6-diethyl-indan-2-ylamino)-1-hydroxy-ethyl]-8-hydroxy-(1h)-quinolin-2-one salt

Also Published As

Publication number Publication date
EP1613599B8 (en) 2011-06-22
TNSN05245A1 (en) 2007-06-11
KR20050119678A (ko) 2005-12-21
ECSP056059A (es) 2006-01-27
HK1086833A1 (en) 2006-09-29
CA2520990C (en) 2011-08-09
DE602004030553D1 (de) 2011-01-27
ZA200507603B (en) 2006-11-29
TWI324151B (en) 2010-05-01
NO20055099D0 (no) 2005-11-01
CA2520990A1 (en) 2004-10-14
US7605267B2 (en) 2009-10-20
CO5700779A2 (es) 2006-11-30
MXPA05010616A (es) 2005-11-23
NZ542623A (en) 2008-07-31
JP2006522055A (ja) 2006-09-28
MY141871A (en) 2010-07-16
PE20050211A1 (es) 2005-04-27
MA27761A1 (fr) 2006-02-01
KR101073740B1 (ko) 2011-10-13
JP4726778B2 (ja) 2011-07-20
SI1613599T1 (sl) 2011-04-29
WO2004087668A1 (en) 2004-10-14
EP1613599A1 (en) 2006-01-11
PL1613599T3 (pl) 2011-05-31
RU2339621C2 (ru) 2008-11-27
US20060189653A1 (en) 2006-08-24
AR043825A1 (es) 2005-08-17
BRPI0409154B1 (pt) 2014-03-25
CL2004000706A1 (es) 2005-01-14
ES2358193T3 (es) 2011-05-06
AU2004226212B2 (en) 2008-02-21
EP1613599B1 (en) 2010-12-15
BRPI0409154A (pt) 2006-03-28
DK1613599T3 (da) 2011-03-28
AR103508A2 (es) 2017-05-17
NO331980B1 (no) 2012-05-21
PT1613599E (pt) 2011-03-17
AU2004226212A1 (en) 2004-10-14
CY1111515T1 (el) 2015-08-05
CN1774423A (zh) 2006-05-17
IL171053A (en) 2010-12-30
TW200504025A (en) 2005-02-01
IS8095A (is) 2005-10-27
ATE491690T1 (de) 2011-01-15
IS2800B (is) 2012-09-15
NO20055099L (no) 2006-01-02
PE20100399A1 (es) 2010-06-01

Similar Documents

Publication Publication Date Title
HRP20110184T1 (hr) Postupak priprave 5-(haloacetil)-8-(supstituirani oksi)-(1h)-kinolin-2-ona
SU1657064A3 (ru) Способ получени производных тетрагидро(фуро- или тиено)-[2,3-с]пиридина или их гидрохлоридов или четвертичных солей с метилйодидом
ES2536923T3 (es) Proceso e intermedios para preparar inhibidores de la integrasa del VIH
US7057067B2 (en) Process for the preparation of 2-halobenzoic acids
HRP20161369T1 (hr) Postupak za proizvodnju intermedijera estetrola
US20100081688A1 (en) Process for the preparation of montelukast, and intermediates therefor
JP2006522055A5 (enExample)
KR920010571B1 (ko) 플루오르화 벤조일 화합물
CN113233974A (zh) 一种酰基氟化物的合成方法
TW201833065A (zh) 製備經環丙基取代之苯乙酮的方法
ES2400943T3 (es) Proceso para la preparación de N-alquil-2(hidroxi-4-benzoil)-3-benzofuranos y compuestos intermedios de los mismos
US4785121A (en) Preparation of halophthalic anhydrides
CN106565626A (zh) 2‑氨基‑4‑芳基‑5‑甲硫基噻唑类化合物的合成方法
IE39419L (en) Bis-(benzyl) acetic acid derivatives.
WO2005063661A1 (ja) フッ素化剤およびそれを用いる含フッ素化合物の製造方法
JPH01254659A (ja) ピロール誘導体
TH2103000895C3 (th) อนุพันธ์ของสาร 5,7-ไดไฮดรอกซี-3-เมทอกซี ฟลาโวน (5,7-dihydroxy-3-methoxy flavone)
CN109956968B (zh) 铽有机膦酸配合物的制备方法及其在水体检测中的应用
ES8105737A1 (es) Un procedimiento para la preparacion de un derivado de un acido penicilanico 6b-sustituido
EP0015140B1 (en) Thermolysis of 2-(3-aryl-isoxazol-5-yl)benzoic acids, salts and halides from 3'-(aryl)-spiro(isobenzofuran-1(3h),5'(4'h)isoxazol)-3-ones
Wojakowska et al. Phase diagram for the CuBr–CsBr system
GB2149795A (en) Thio substituted triaryl sulphonium salts
CN104387265B (zh) 一种4,5-二羟基-2-甲基苯甲酸的制备方法
IT8222986A1 (it) Procedimento per la produzione di 2-ammino-4-idrossi-5-alogeno-pirimidine
CN103772340B (zh) 一种芳基取代萘并吡喃类化合物的改进合成方法